Drugs to beat COVID-19 Favipiravir: Glenmark Begins Phase III Trials
Glenmark Pharamacaueticls has initiated phase -3 clinical trials in India on antiviral tablets favipiravir for which it received approval from...
glenmark Phase III Trials of COVID-19 medicine
